Katarzyna Mazur-Hofsaess

Katarzyna Mazur-Hofsaess is Chief Executive Officer-Care Enablement at Fresenius Medical Care Management AG since 2018.
Holds the position of Chairman-Supervisory Board at Xenios AG.
Serves as Independent Non-Executive Director at Smith & Nephew plc, Smith & Nephew A, and Smith & Nephew INC since 2020.
Director at CD Diagnostics, Inc., National Medical Care (Deutschland) GmbH as Managing Director, and Ottobock SE & Co. KGaA starting 2026.
Formerly Chief Executive Officer-Care Enablement at Fresenius Medical Care AG from 2018 to 2026.
Non-Executive Director at Vifor Fresenius Medical Care Renal Pharma Ltd. Divisional Vice President-Abbott Diagnostics at Abbott Laboratories from 2007 to 2010.
President-Europe, Middle East & Africa Region at Zimmer Biomet Holdings, Inc. from 2015 to 2018 and at Zimmer, Inc. from 2010 to 2015.
General Manager-Poland at Allergy Therapeutics Polska Sp zoo from 1999 to 2001.
Education includes an MBA from the University of Minnesota in 2002, an MBA from Warsaw School of Economics, and a doctorate from the University of Gdansk in 1987.